GlassScriptPhysician profile
Jonathan Stehn
NPI 1811976251
$6,977.72
in general payments reported to CMS, 2019-2025
42 companies · $1,285 in 2025
The $1,285 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $860 · 2022: $1,517 · 2023: $1,472 · 2024: $1,844 · 2025: $1,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,600.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,327.55 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $947.02 | 2021-2025 | |
| Amgen INC. | $853.33 | 2021-2025 | Repatha, Evenity, Otezla |
| Novo Nordisk INC | $525.00 | 2021-2024 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $471.14 | 2022-2025 | Zepbound, Jardiance, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $277.18 | 2021-2024 | Jardiance |
| Pfizer INC. | $252.88 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $196.29 | 2021 | |
| Glaxosmithkline, LLC. | $148.60 | 2024 | Arexvy, Shingrix |
| Daiichi Sankyo INC. | $148.47 | 2021-2025 | Injectafer |
| Biohaven Pharmaceutical Holding Company LTD. | $144.86 | 2022 | |
| Phathom Pharmaceuticals, INC. | $136.69 | 2024-2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $130.61 | 2022-2023 | |
| Madrigal Pharmaceuticals | $108.55 | 2025 | Rezdiffra |
| Intuitive Surgical, INC. | $102.62 | 2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Stehn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.